Belgium· BE-AMP-SAM435714-00

Octreotide Fresenius Kabi 0,5 mg/ml

A octreotide product containing octreotide acetate, registered in Belgium by Fresenius Kabi. The same ATC class is registered in 17 of our 19 countries.

ATC H01CB02

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about octreotide acetateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Octreotide is registered in 17 of 19 countries.

Countries holding a registration under ATC H01CB02 (octreotide), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
10 of them publish a price we can compare per daily dose

Search octreotide products by name

Octreotide · ATC H01CB02

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of octreotide costs, country by country.

Normalised to the WHO defined daily dose (0.7 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Octreotide · price per daily dose (0.7 mg)

USD · FX 28 Sept 2026

CH Switzerland$41.46

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Octreotide Acetate
Manufacturer: Fresenius Kabi
Country: Belgium (BE)
ATC code: H01CB02
ATC class: Octreotide
Defined daily dose: 0.7 mg, P
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 2

be_apb
3094810
be_apb
7706252

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

367 interactions on record for octreotide.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check octreotide against other medicines How interaction checks work

Octreotide · interactions on record

367 records

4 severe
151 moderate
4 minor
168 info

Most severe, free to view

LonafarnibA16AX20severe
PexidartinibL01EX15severe
BexaroteneL01XF03severe
BexarotenL01XX25severe

40 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Octreotide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All octreotide products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Octreotide Ratiopharm, Sandostatin
Bulgaria · Octreotid Lyomark, Октреотид Lai Тева
Cyprus · Octreotide Rompharm, Sandostatin
Czechia · Octreotide Teva, Octreotide Teva B.V.
Germany · Octreo Ratiopharm, Octreotid Bendalis
Denmark · Octreoanne, Octreotid Sun
Estonia · Octreotide Teva, Sandostatin
Spain · Octreotida Gp-Pharm, Octreotida Sun
Finland · Octreotide Orion, Octreotide Ratiopharm
France · Octreotide Arrow, Octreotide Hospira
United Kingdom (Northern Ireland) · Octreotide Chemi, Octreotide Hospira Uk
Greece · Okrodin, Sandostatin
Croatia · Oktreotid Teva, Sandostatin
Hungary · Oktreotid Teva, Sandostatin
Ireland · Octreotide Pfizer Healthcare Ireland, Olatuton
Iceland · Octreoanne, Oczyesa
Italy · Octreotide Bioindustria L.I.M., Octreotide Sun
Liechtenstein · Oczyesa
Lithuania · Octreotide Teva, Sandostatin
Luxembourg · Octreoteva Long Acting, Sandostatine
Latvia · Sandostatin, Sandostatin Lar
Malta · Sandostatin, Sandostatin Lar
Netherlands · Octreotide Bendalis, Octreotide Depot Teva
Norway · Octreoanne, Octreotide Orion
Poland · Okteva, Sandostatin
Portugal · Octreotido Color, Octreotido Depot Teva
Romania · Octreotidă Rompharm, Octreotidă Teva
Sweden · Octreotide Orion, Octreotide Teva
Slovenia · Oktreotid Teva, Sandostatin
Slovakia · Sandostatin, Sandostatin Lar

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/ae9dac42-3417-4b99-a6ef-ead5e474919f
GET /v1/drugs/ae9dac42-3417-4b99-a6ef-ead5e474919f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Octreotide Fresenius Kabi 0,5 mg/ml",
  "name_fr": "Octreotide Fresenius Kabi 0,5 mg/ml",
  "name_nl": "Octreotide Fresenius Kabi 0,5 mg/ml",
  "amp_code": "SAM435714-00",
  "strengths": [
    "0.5000"
  ],
  "pack_count": 3,
  "substances": [
    "Octreotide Acetate",
    "Octreotide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Octreotide",
  "authorisation_numbers": [
    "BE435714"
  ]
}

API reference MCP server Plans

See everything about octreotide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console